Search

ProQR Appoints Naveed Shams, MD, PhD as Chief Scientific Officer

Press release

Proven leader with deep worldwide ophthalmology experience, including multiple approvals globally

oktober 05, 2020
ProQR to Present at Scientific and Investor Conferences in September

Press release

LEIDEN, the Netherlands, Sept. 06, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.

september 06, 2016
ProQR to Present at Upcoming JMP Securities Life Sciences Conference

Press release

… ProQR to Present at Upcoming JMP Securities Life Sciences … will be accessible from the “Investors & Media” section of ProQR’s website ( www.proqr.com ) under “ Eve n ts ”. The archived webcast will …

juni 10, 2021
ProQR Announces Conference Call to Discuss Axiomer® RNA Editing Platform

Press release

LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 22, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.

december 22, 2022
ProQR to Present at Upcoming Scientific Meeting and Investor Conference

Press release

LEIDEN, the Netherlands, Feb. 06, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.

februari 06, 2018
ProQR Announces Financial Results for the Third Quarter of 2018

Press release

LEIDEN, Netherlands and CAMBRIDGE, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.

november 07, 2018
ProQR Therapeutics Announces Results for the Third Quarter of 2014

Press release

LEIDEN, the Netherlands, Nov. 24, 2014 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.

november 24, 2014
ProQR to Present at the Chardan Inaugural Gene Therapy Conference

Press release

… ProQR to Present at the Chardan Inaugural Gene Therapy … be accessible from the ‘Investor Relations’ section of ProQR’s website ( www.proqr.com ) under ‘Events and Presentations’. The …

oktober 06, 2017
ProQR Announces Financial Results for the Second Quarter of 2018

Press release

LEIDEN, The Netherlands, Aug. 08, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.

augustus 08, 2018
ProQR Therapeutics Announces Results for the First Quarter of 2015

Press release

LEIDEN, the Netherlands, May 21, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.

mei 21, 2015